• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

    2021-05-10 08:56:48LingJiaGaoYuQinZhuLiangXu
    Hepatoma Research 2021年4期

    Ling-Jia Gao, Yu-Qin Zhu, Liang Xu

    School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.

    Abstract Nonalcoholic fatty liver disease is a major contributor to chronic liver disease worldwide, and 10%-20% of nonalcoholic fatty liver progresses to nonalcoholic steatohepatitis (NASH). Astaxanthin is a kind of natural carotenoid, mainly derived from microorganisms and marine organisms. Due to its special chemical structure,astaxanthin has strong antioxidant activity and has become one of the hotspots of marine natural product research.Considering the unique chemical properties of astaxanthin and the complex pathogenic mechanism of NASH,astaxanthin is regarded as a significant drug for the prevention and treatment of NASH. Thus, this review comprehensively describes the mechanisms and the utility of astaxanthin in the prevention and treatment of NASH from seven aspects: antioxidative stress, inhibition of inflammation and promotion of M2 macrophage polarization,improvement in mitochondrial oxidative respiration, regulation of lipid metabolism, amelioration of insulin resistance, suppression of fibrosis, and liver tumor formation. Collectively, the goal of this work is to provide a beneficial reference for the application value and development prospect of astaxanthin in NASH.

    Keywords: Nonalcoholic fatty liver disease, astaxanthin, fibrosis, insulin resistance, mitochondrial dysfunction,oxidative stress

    INTRODUCTION

    Nonalcoholic fatty liver disease (NAFLD) has become one of the most prevalent forms of chronic liver disease in most countries, and is frequently associated with obesity, metabolic syndrome, and type 2 diabetes[1]. NAFLD is characterized by the accumulation of triglyceride (TG) fats by more than 5% to 10% of the liver weight in the absence of superfluous alcohol consumption. Nonalcoholic steatohepatitis (NASH),an advanced form of NAFLD, is characterized by hepatocellular steatosis, lobular inflammation, and fibrosis, and may lead to liver cirrhosis and hepatocellular carcinoma[2-4]. According to global epidemiological research, the global prevalence of NAFLD is increasing year by year and reached approximately 25% by 2016[5-7]. Studies have shown that NAFLD is rapidly increasing as an indicator for liver transplantation, and its incidence in the United States is currently as high as one-third of the total population[8].

    For the pathogenesis of NASH, the widely accepted theory is the “second or multiple hits” hypothesis[9,10], as show as Figure 1. Although insulin resistance, enhanced oxidative stress followed by lipid peroxidation, and rising proinflammatory cytokine release are believed to be the major causes of progression to NASH[11,12], the concrete mechanisms remains obscure. Currently, NAFLD is considered to be an integral part of metabolic syndrome with insulin resistance as the central risk factor. Metabolic syndrome is often characterized by oxidative stress, a disturbance in the balance between the production of reactive oxygen species (ROS) and antioxidant defenses[13].

    Currently, several pharmacological agents, such as metformin, thiazolidinediones, and vitamin E have been tested as treatments for NASH in clinical trials[14-16]. However, these agents are generally insufficient to ameliorate liver inflammation and fibrosis, and have raised safety concerns. Therefore, a potential therapy with minimal adverse effects is eagerly awaiting. It has recently become clear that the effects of astaxanthin go beyond its antioxidant properties. Astaxanthin is a xanthophyll carotenoid found in marine organisms,including salmon, shrimp, crustaceans, and algae such as Haematococcus pluvialis[17,18]. Accumulating evidence suggests that astaxanthin could prevent or even reverse NASH by improving oxidative stress,inflammation, lipid metabolism, insulin resistance and fibrosis.

    The objective of this review is to summarize the bio-functions of astaxanthin in the prevention of NASH.

    SOURCE, SYNTHETIC AND BIOLOGICAL ACTIVITY OF ASTAXANTHIN

    Astaxanthin is a secondary carotenoid with a chemical structure of 3,3’-dihydroxy-4,4’-diketo-β, β’-carotene,which is known for its strong antioxidant activity. It is widely found in nature, such as leaves, flowers, fruits,feathers of flamingos, most fishes, members of the frog family, crustaceans, and the unicellular alga,Haematococcus pluvialis, which is the most ideal source of natural astaxanthin[17,19]. At present, astaxanthin is mainly obtained by the biological extraction of aquatic products and by artificial synthesis from carotene as the raw material. Because synthetic astaxanthin is expensive and less natural than natural astaxanthin in terms of chemical safety and biofunctionality, currently astaxanthin is almost always obtained by biological extraction for its use as a dietary supplement.

    At present, astaxanthin is widely used in the food industry as a dietary supplement in a growing number of countries. In 1987, the US Food and Drug Administration (FDA) approved astaxanthin as a feed additive for animal and fish feed; in 1999, the FDA authorized it as a dietary supplement for humans[20]. Astaxanthin is lipophilic and hydrophilic, it is absorbed by intestinal epithelial cells in the small intestine and then esterified. It is passively diffused and combined with fat molecules. The unesterified part is combined with chylomicrons and then passed through the lymphatic system for transport into the liver. Spiller and Dewell[21]used a randomized, controlled, double-blind approach to assess the safety of oral administration of astaxanthin (6 mg/d) in healthy individuals. There was no significant difference in blood pressure and various biochemical parameters at 4 and 8 weeks. Humans cannot synthesize astaxanthin, and the ingested astaxanthin cannot be converted to vitamin A; excessive intake of astaxanthin will thus not cause hypervitaminosis A[22,23]. Astaxanthin has physiological functions such as inhibiting tumorigenesis,protecting the nervous system, preventing diabetes and cardiovascular diseases[17,24-27], and it is widely used in various industries such as food, cosmetics, health care products, and aquaculture. Considering the biological characteristics of astaxanthin and the complex pathogenesis of NASH, it remains unknown whether astaxanthin can be used to treat NASH; the underlying mechanism of action also remains obscured.

    Figure 1. Multiple-hit hypothesis of the progression of NAFLD/NASH. Dietary habits, environmental, and genetic factors cause overweight or obesity and change the intestinal microbiome. This results in increased serum FFA and inflammatory factor (adipo-, cytoand/or chemokines) levels and eventually leads to insulin resistance. Furthermore, insulin resistance leads to an increase in DNL in the liver and increases the synthesis and accumulation of TG and toxic levels of fatty acids. Fat accumulation in the liver in the form of TG leads to liver steatosis (NAFL). Free cholesterol and other lipid metabolites cause mitochondrial dysfunction and subsequent oxidative stress, and ROS release and ER stress further activates UPR; which collectively lead to hepatic inflammation and fibrosis (NASH).NAFLD: Nonalcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis; FFAs: free fatty acids; DNL: de novo lipogenesis; LPS:lipopolysaccharide; TNFα: tumor necrosis factor alpha: IL-6: interleukin-6; TG: triglycerides; ER: endoplasmic reticulum; UPR: unfolded protein response; ROS: reactive oxygen species.

    THE MECHANISM OF ASTAXANTHIN IN THE PREVENTION OF NASH

    Anti-oxidative stress effect

    As stated above, oxidative stress is one of the various factors that contribute to the “multiple hits” in the pathogenesis of NASH and is the main contributor of liver injury and disease progression in NAFLD.Indeed, several oxidative stress biomarkers that have been determined in clinical models of NAFLD include nitric oxide (NO), lipid peroxidation products [lipid peroxides, thiobarbituric acid reactive substances(TBARS), Hydroperoxides, 8-isoprostane and 4-Hydroxynonenal], protein oxidation products (protein carbonyl, nitrotyrosine), DNA oxidation product (8-OH-dG), and CYP2E1[28,29]. Additionally, two clinical studies have found that increases in oxidative stressin vivo,measured by urinary 8-iso-prostaglandin F2α(8-iso-PGF2α), which is derived from the non-enzymatic oxidation of arachidonic acid and serum levels of soluble NOX2-derived peptide (sNOX2-dp), is an indicator of NOX2 activation, a NADPH oxidase isoform involved in ROS generation[30,31].

    Oxidative stress damage is due to the imbalance of oxidation and anti-oxidation processes in the body that cause tissue injury induced by excessive production of free radicals, ROS and reactive nitrogen species(RNS). Excessive ROS can react with proteins, lipids and DNA through a chain reaction, thereby destroying homeostasis and causing tissue damage[32,33]. However, studies have shown that ROS can be eliminated from their oxidative activity by antioxidants such as carotenoids. Carotenoids contain polyene chains and longchain conjugated double bonds, which are responsible for antioxidant activities, acting by quenching singlet oxygen to terminate the free radical chain reaction in the organism[34,35]. Astaxanthin, one of the most prominent carotenoids with antioxidant activity, can penetrate the whole cell membrane, reduce membrane permeability, and limit the entry of peroxide promoters such as hydrogen peroxide and tert-butyl hydroperoxide into the cell[36,37]. Thus, oxidative damage to pivotal molecules in cells can be prevented.Astaxanthin scavenges oxygen free radicals and prevents lipid auto-oxidation with a capacity that is 6,000 times greater than that of vitamin C, 800 times that of coenzyme Q10, 550 times that of vitamin E, 200 times that of tea polyphenols, and 10 times that of beta carotene[17,38]; rightfully therefore known as a “super antioxidant”. Jorgensenet al.[39]found that astaxanthin is more effective than beta-carotene and zeaxanthin in preventing excessive oxidation of unsaturated fatty acid methyl esters. This conclusion has also been verified in various biofilm models, including phosphatidylcholine liposomes[40]and rat liver microsomes[37].

    Nakagawaet al.[41]reported that supplementation with astaxanthin (6 and 12 mg/d) in 30 healthy subjects decreased erythrocyte phospholipid hydroperoxide (PLOOH) levels and increased astaxanthin levels, 12 weeks after administration. An animal study showed that the concentration of catalase (CAT), superoxide dismutase (SOD) and peroxidase (POD) increased significantly in the plasma and hepatocytes of rats that were fed Haematococcus pluvialis[42]. In obese and overweight adults, astaxanthin supplementation (5 and 20 mg/d) dramatically reduced the level of biomarkers related to oxidative stress, including malondialdehyde (MDA) and isoprostane, and increased SOD and total antioxidant capacity (TAC). These findings indicate the strong antioxidant capacity of astaxanthinin vivo[43].

    Anti-inflammatory effect and enhancement in M2 macrophage polarization

    Given the strong link between inflammation and oxidative stress, it is not surprising that astaxanthin has been studied as an agent to attenuate inflammation.In vitro, astaxanthin has been shown to reduce proinflammatory markers in several cell lines, such as rat alveolar macrophages[44], U937 cells[45], RAW 264.7 cells[46], Thp-1 cells[24], proximal renal tubular epithelial cells[47], HUVECs[48], and human lymphocytes[49].

    Wanet al.[50]demonstrated that M2 macrophage/Kupffer cells promote apoptosis in M1 macrophage/Kupffer cells and inhibit NAFLD progression. Astaxanthin restrains M1 macrophage/Kupffer cells and increases M2 macrophage/Kupffer cells, reducing liver recruitment of CD4+and CD8+cells and inhibiting inflammatory responses in NAFLD[51]. Inflammatory factors aggravate the progression of NAFLD; however, astaxanthin reduces the levels of interleukin (IL)-6 and tumor necrosis factor (TNF) α in the liver through proliferator-activated receptor α (PPARα) to alleviate inflammation[52]. When NASH was induced by diet, administration of natural astaxanthin (0.02%, ≈ 20 mg/kg BW) reduced liver inflammation and insulin resistance in C57BL/6J mice[51]. Compared to vitamin E, astaxanthin was more effective in preventing and treating NASH in this animal model[51].

    Recently, the gut-liver axis has been shown to mediate the NASH progression[53]. Notably, liver lipopolysaccharide (LPS) is produced by intestinal microbiota, which were known to induce oxidative stress and inflammation. The LPS/toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) signaling is critical for the activation of inflammatory pathways associated with NASH[54]. Lumenget al.[55]found that in primary macrophages and RAW 264.7 cells stimulated by LPS, astaxanthin significantly reduced the levels of NO, prostaglandin E2 (PGE2), TNFα, and IL-1β by inhibiting NF-κB activation. Macedoet al.[56]showed that astaxanthin can obviously reduce the production of proinflammatory cytokines, such as TNFα and IL-6, secreted by LPS-induced neutrophils and enhance the phagocytosis and bactericidal ability of neutrophils by inhibiting the production of O2-(superoxide anion radical) and H2O2.

    Improvement of mitochondrial respiratory chain

    Numerous studies have shown that excessive ROS can cause oxidative damage to mitochondria. In turn,damage to the mitochondrial respiratory chain complex I and III releases electrons to produce a large amount of ROS; approximately 90% of ROS in cells are produced from mitochondria. Superfluous ROS cause mitochondrial structural abnormalities and functional deficits, mainly manifested in decreased mitochondrial membrane potential, mitochondrial mutation, uncoupling of the mitochondrial respiratory chain, increased free radical production, and decreased adenosine triphosphate (ATP) production.Dysfunctional mitochondria trigger inflammatory cytokine production and often lead to the development of degenerative diseases, aging, metabolic diseases, cardiovascular diseases and so on.

    A growing body of studies has also involved astaxanthin in improving cellular mitochondrial oxidative respiratory chains to resist oxidative stress damage, and recent results hypothesize that astaxanthin has a“mitochondrial targeting” effect in cells. Fanet al.[57]verified that astaxanthin significantly attenuated homocysteine-induced cytotoxicity of H9C2 cells by inhibiting mitochondria-mediated apoptosis and blocked homocysteine-induced mitochondrial dysfunction by modulating the expression of the Bcl-2 family. Importantly, astaxanthin also significantly inhibits homocysteine-induced cardiotoxicityin vivoas well as improves angiogenesis. A similar study has shown that astaxanthin has the potential to reverse homocysteine-induced neurotoxicity and apoptosis by inhibiting mitochondrial dysfunction and ROSmediated oxidative damage and regulating the MAPK and AKT pathways[58]. After treatment of gastric epithelial cells with astaxanthin, Kimet al.[59]found that Helicobacter pylori-induced increases in ROS,mitochondrial dysfunction, NF-κB activation, and IL-8 expression were alleviated without affecting NADPH oxidase activity, indicating thereby that astaxanthin could prevent oxidative stress-mediated Helicobacter pylori infection that is associated with gastric inflammation Yuet al.[60]also found that astaxanthin can improve heat-induced skeletal muscle oxidative damage. In mouse C2C12 myoblasts exposed to heat stress at 43 ℃, astaxanthin lessened heat-induced ROS production in a concentrationdependent manner (1-20 μM), preventing mitochondrial disruption, depolarization and apoptotic cell death. Astaxanthin increases the protein expression of peroxisome proliferator-activated receptor γ coactivator-1β (PGC-1α) and mitochondrial transcription factor A (TFAM) at 37 ℃, and maintains mitochondrial tubular structure and a normal membrane potential (ΔΨm), i.e., maintainance of mitochondrial integrity and function. Data from Manoet al.[61]showed that astaxanthin inhibits oxidation and nitridation, which leads to apoptosis and lipid peroxidation of cytochrome c peroxidase, although its efficiency varies with membrane pH and lipid composition. It is hypothesized that astaxanthin is endowed with pH-dependent antioxidant/antiapoptotic properties in respiratory mitochondria. Astaxanthin and tocopherol nanoemulsions (NEs) were prepared using sodium caseinate (AS-AT/SC NEs) as a raw material to protect cells from ROS, oxidative stress, and mitochondrial membrane potential through mitochondriamediated apoptosis to prevent cell death, demonstrating therefore that apoptosis induced by AS-AT/SC NEs may be a potential method to destroy cancer cells[62]. Taken together, astaxanthin can ameliorate mitochondrial glutathione (GSH) activity, complex I activity, ATPase activity, mitochondrial membrane potential and fluidity by ROS, and excessively open the membrane permeability transition pore (MPTP)[63].

    Although an accurate discussion is lacking on the mechanisms by which mitochondria might assist in the prevention and treatment of NASH, the above studies suggest that mitochondrial function plays an indelible role in NASH.

    Lipid metabolism

    Jiaet al.[52]administered astaxanthin orally to C57BL/6J mice that were fed a high-fat diet for 8 weeks and found that astaxanthin could improve liver lipid accumulation and decrease liver TG levels. Astaxanthin was found to regulate PPAR levels. Activated PPARα increases liver fatty acid transport, metabolism, and oxidation levels; inhibits liver fat accumulation; induces hepatocyte autophagy; and cleaves lipid droplets through AMP-activated protein kinase/PGC-1α[64-66]. PPARα has become a key target for the treatment of NAFLD - activation of PPARγ regulates lipid synthesis-related gene expression and promotes fatty acid storage, and PPARγ overexpression induces hepatic lipid accumulation[67]. Astaxanthin activates PPARα,inhibits PPARγ expression, and reduces intrahepatic fat synthesis[63]. In addition, astaxanthin inhibits the AKT-mTOR pathway, which also causes autophagy of liver cells and breaks down lipid droplets stored in the liver[52]. Furthermore, astaxanthin reduces liver fatty acid synthesizing enzyme (FASN) mRNA levels and directly inhibitsde novosynthesis of fat[68].

    In vitroand clinical studies have shown that the continuous use of astaxanthin for 2 weeks can significantly prolong the oxidation time of low-density lipoprotein (LDL). Astaxanthin can inhibit the production of ox-LDL and the utilization of ox-LDL by the activation of macrophages along with the enhanced expression of PPARα. At the same time, it inhibits the expression of PPARγ and reduces the synthesis of fat in the liver.Augustiet al.[69]found that astaxanthin can significantly reduce oxidative stress damage and program lower blood lipid levels in rabbits with hypercholesterolemia. In patients with hypertriglyceridemia, serum TG levels of patients with long-term oral astaxanthin were significantly lower than those in the control group,while adiponectin and high-density lipoprotein (HDL) levels were significantly increased[70]. In obese and overweight people, oral astaxanthin lowers apolipoprotein B and LDL cholesterol levels and improves oxidative damage[43]. It has been reported that astaxanthin also reduces platelet aggregation and promote fibrinolytic activity in rats with hyperlipidemia induced by a high-fat diet. These positive effects are related to decreased serum lipid and lipoprotein levels, antioxidant production, and protection of endothelial cells[71].

    Amelioration of insulin resistance

    Insulin resistance is the major contributor to obesity, type 2 diabetes, and NAFLD. Insulin activates the tyrosine kinase activity of insulin receptor-beta (IRβ) subunits, which phosphorylates insulin receptor substrate, IRS, to activate the insulin metabolism pathway: IRS1-PI3K-AKT (insulin receptor substrate 1,phosphoinositide 3-kinase, serine/threonine kinase). When serine/threonine protein kinases, such as Jun Nterminal kinases (JNK) and mitogen-activated protein kinase 3 (ERK-1), inhibitors of nuclear factor kappa-B kinase (NF-κB) subunit beta (IKK-β), phosphorylate IRβ and IRS1, the IRS1-PI3K-AKT pathway is blocked and its activity decreases, and insulin resistance occurs accordingly[72,73]. The activation of JNK and NF-κB, stimulated by sustained endoplasmic reticulum (ER) stress also causes insulin resistance[74].Bhuvaneswariet al.[75,76]established a mouse model of type 2 diabetes induced by a high fructose-fat diet(HFFD) to study the effects of astaxanthin on hepatic insulin signaling and glucose metabolism.Astaxanthin intervention significantly improved insulin sensitivity in the HFFD group. This is because astaxanthin restores the insulin metabolic pathway by decreasing the activity of JNK and ERK-1 to ameliorate insulin resistance in the liver. Niet al.[51]constructed a diet-induced NASH mouse model that consisted of a high-fat, high cholesterol, and cholate diet (CL). In the fasting and fed states, glucose intolerance and hyperinsulinemia that accompanied the CL diet were significantly ameliorated by astaxanthin, and vitamin E treatment also reduced the plasma insulin levels to some extent. This result was related to the fact that astaxanthin-treated mice produced more insulin-stimulated phosphorylated IRβ and AKT than did control mice, while vitamin E had little effect on hepatic insulin signaling.

    Anti-fibrosis effect

    Hepatic fibrosis is a wound healing response characterized by excessive accumulation of extracellular matrix. Hepatic stellate cell (HSC) activation plays a key role in liver fibrosis[77]. Transforming growth factor beta 1 (TGF-β1) is the most effective profibrotic cytokine[78]. TGF-β1/Smad3 signaling regulates transcription of key genes in fibrosis, causing liver fibrosis. The imbalance in matrix metalloproteinases(MMPs) and MMP inhibitors (tissue inhibitor of MMPs, TIMPs) accelerates the progression of liver fibrosis, and TGF-β1 regulates the expression of MMPs and TIMPs. Yanget al.[79]confirmed that astaxanthin can reduce the expression of the TGF-β1-induced fibrosis genes α-SMA and Col1A1 and effectively inhibit fibrosis in LX-2 cells. The mechanism is that astaxanthin downregulates Smad3 phosphorylation and nuclear translocation induced by TGF-β1. Yanget al.[79]also observed that when activated primary HSCs were coincubated with astaxanthin, α-SMA mRNA and protein levels were significantly downregulated, indicating that astaxanthin can inhibit the early activation of resting HSCs.Shenet al.[80]studied the protective effect of astaxanthin on liver fibrosis induced by carbon tetrachloride(CCl4) and bile duct ligation. The results showed that astaxanthin effectively improved the pathological damage of liver fibrosis. Astaxanthin reduces the expression of TGF-β1 by downregulating nuclear NF-κB levels, maintains the balance between MMP2 and TIMP1, and inhibits the activation of HSCs and the formation of extracellular matrix (ECM). Hernandez-Geaet al.[81]reported that autophagic degradation of lipid droplets in HSCs provides energy for HSC activation, thereby aggravating the process of liver fibrosis.Astaxanthin alleviates HSC autophagy levels, reduces nutrient supply, and inhibits HSC activation. In addition, histone acetylation, as an epigenetic model, is involved in the activation of HSCs and the process of liver fibrosis[82]. Some studies have found that astaxanthin significantly suppresses the activation of HSCs by decreasing the expression of histone deacetylase 9 (HDAC9); HDAC3 and HDAC4 may also be involved in this process[74].

    Antitumor formation

    Hepatocellular carcinoma (HCC) is a malignant tumor with extremely high morbidity and mortality.Multiple signaling pathways, such as NF-κB p65, Wnt/beta-catenin, JAK/STAT, Hedgehog, Ras/MAPK and so on, are closely related to the development of liver cancer[83,84]. In the aflatoxin (AFB1)-induced liver cancer model, astaxanthin markedly reduced the number and size of liver cancer lesions. In-depth studies have found that astaxanthin significantly inhibits AFB1-induced single-strand DNA breaks and AFB1 binding to liver DNA and plasma albumin[85]. Tripathiet al.[86]found that astaxanthin inhibits cyclophosphamide-induced liver tumors in the early stage in rats. The Nrf2-ARE pathway is an endogenous antioxidant stress pathway that regulates the expression of SOD and DNA repair enzymes (e.g., OGG1,XRCC1, XPD, and XPG), which play an important role in tumorigenesis and progression[87,88]. Astaxanthin can inhibit the occurrence and development of liver cancer, which in turn, may be related to the activation of Nrf2-ARE pathway.

    Songet al.[89]confirmed that astaxanthin induces mitochondria-mediated apoptosis in the mouse liver cancer cell line CBRH-7919 by inhibiting the JAK/STAT3 pathway. In addition, astaxanthin inhibits liver tumorigenesis and may be involved in the regulation of NM23, which encodes a nucleoside diphosphate kinase. The upregulated expression of this protein is beneficial to the correct assembly of the cytoskeleton and the transmission of T protein signaling. Liet al.[90]confirmed that astaxanthin can prevent the proliferation of human hepatoma cells LM3 and SMMC-7721 and induce their apoptosis. The possible mechanism is that astaxanthin inhibits the NF-κB and Wnt/beta-catenin signaling pathways and regulates downstream the expression of the antiapoptotic protein, Bcl-2, and apoptosis-related gene, Bax; thereby promoting apoptosis of tumor cells. At the same time, astaxanthin decreases the phosphorylation of glycogen synthetase kinase-3 beta (GSK-3β) and inhibits tumor cell infiltration. Consistent with these findings, Shaoet al.[91]showed that astaxanthin can inhibit the proliferation of mouse hepatoma cell line H22 and arrest cells in the mitotic G2 phase.

    Figure 2. Mechanisms of the effects of astaxanthin on NASH. The strong antioxidant effect of astaxanthin can significantly inhibit oxidative stress, thereby reducing mitochondrial damage and endoplasmic reticulum stress, leading to a shift to M2 macrophage polarization and ultimately reversing liver steatosis, inflammation, and insulin resistance. Moreover, astaxanthin can reduce the activation of hepatic stellate cells to ameliorate hepatic fibrosis as a result of M1/M2 macrophage transformation. In addition,astaxanthin can inhibit the generation of hepatocyte tumors. Thus, astaxanthin prevents the development of NAFLD by inhibiting lipid accumulation, inflammation, and fibrosis in the liver. NAFLD: Nonalcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis; KC:Kupffer cell; M1: proinflammatory macrophages; M2: anti-inflammatory macrophages; HSC: hepatic stellate cells; HCC: hepatocellular carcinoma.

    The increase inde novofat synthesis is a common feature of many malignant tumors. FASN is expressed in a variety of malignant tumors, including liver cancer[92,93], and astaxanthin downregulates liver FASN mRNA levels to restrain liver tumorigenesis[94]. In addition, adipocytokines, another key regulator of the fat synthesis pathway, play an important role in repressing the proliferation of human liver tumor cells and inducing apoptosis. Astaxanthin observably inhibits liver tumorigenesis in obese mice by increasing serum adipocytokine levels[95].

    CONCLUSION

    Astaxanthin has been recognized as a new food resource and is expected to have good application prospects in health food and dietary supplements. The prevalence of NASH continues to persist globally, and its complex and diverse pathogenesis makes it difficult to diagnose and treat. Currently, there are no FDAapproved standard drug regimens in the guidelines for management of NASH. At present, great progress has been made in researching the antioxidant activity of astaxanthin. A large number of studies have demonstrated that astaxanthin can prevent or treat NASH through various mechanisms [Figure 2]. Most studies on the influence of astaxanthin on NASH remain at the cellular and animal experiment level.However, the presented research in this work on the prevention and treatment of NASH by astaxanthin indicates that there is broad potential and hope for the application of astaxanthin in NASH. As a futuristic goal, we still need large-scale clinical trials to verify the actual effects of astaxanthin on the human body and provide a theoretical basis to continually explore the beneficial effects of astaxanthin antioxidant activity on the human body.

    DECLARATIONS

    Authors’ contributions

    Contributed to the drafting and writing of the manuscript: Gao LJ, Zhu YQ, Xu L

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    This study was supported by Xinmiao Talents Program of Zhejiang Province granted to L.G (2019R413070)and Wenzhou Municipal Science and Technology Bureau granted to L.X. (Y20190049).

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    ? The Author(s) 2021.

    国产熟女欧美一区二区| 亚洲成人精品中文字幕电影| 干丝袜人妻中文字幕| 九九热线精品视视频播放| 全区人妻精品视频| 小蜜桃在线观看免费完整版高清| 高清毛片免费看| 国产黄a三级三级三级人| eeuss影院久久| 亚洲精品亚洲一区二区| 三级经典国产精品| 国产精品人妻久久久久久| 中文字幕人妻熟人妻熟丝袜美| 最近的中文字幕免费完整| 国产淫片久久久久久久久| 日本一二三区视频观看| 亚洲婷婷狠狠爱综合网| 日日干狠狠操夜夜爽| 91久久精品国产一区二区三区| 精品午夜福利在线看| 国产精品久久久久久精品电影| av天堂在线播放| 日本-黄色视频高清免费观看| 在线观看免费视频日本深夜| 国产免费男女视频| 内射极品少妇av片p| 在线播放无遮挡| 啦啦啦观看免费观看视频高清| 一卡2卡三卡四卡精品乱码亚洲| 久久人人爽人人片av| 久99久视频精品免费| 亚洲aⅴ乱码一区二区在线播放| 激情 狠狠 欧美| 精品久久久久久久久av| 亚洲精品色激情综合| www.色视频.com| 91麻豆精品激情在线观看国产| 亚洲国产欧美在线一区| 中文字幕av成人在线电影| 精品国内亚洲2022精品成人| 国产成人影院久久av| av国产免费在线观看| 日日摸夜夜添夜夜添av毛片| 精品久久久噜噜| 亚洲,欧美,日韩| 亚洲av二区三区四区| 亚洲人成网站在线观看播放| 久久精品国产亚洲网站| 国产精华一区二区三区| 一夜夜www| 亚洲综合色惰| 国产成人精品久久久久久| 天天一区二区日本电影三级| 97人妻精品一区二区三区麻豆| 2021天堂中文幕一二区在线观| 亚洲国产日韩欧美精品在线观看| 蜜桃久久精品国产亚洲av| 少妇人妻精品综合一区二区 | 3wmmmm亚洲av在线观看| 日本免费一区二区三区高清不卡| 欧美区成人在线视频| 日韩欧美在线乱码| 久久久a久久爽久久v久久| 久久精品国产亚洲网站| av视频在线观看入口| or卡值多少钱| 精品人妻视频免费看| 在线观看免费视频日本深夜| 黄色一级大片看看| 一级毛片aaaaaa免费看小| 色视频www国产| 国产精品久久视频播放| 我要看日韩黄色一级片| 99久久中文字幕三级久久日本| 国产精品福利在线免费观看| 插逼视频在线观看| 久久久久免费精品人妻一区二区| 国产乱人偷精品视频| 桃色一区二区三区在线观看| 97热精品久久久久久| 一夜夜www| 欧美一区二区亚洲| 亚洲精品日韩av片在线观看| 精品一区二区三区人妻视频| 中文资源天堂在线| a级一级毛片免费在线观看| 99热这里只有精品一区| 成年免费大片在线观看| 给我免费播放毛片高清在线观看| 99九九线精品视频在线观看视频| 精品午夜福利在线看| 久久国产乱子免费精品| 精品一区二区三区人妻视频| 91精品一卡2卡3卡4卡| 免费观看精品视频网站| 免费看日本二区| 久久精品国产99精品国产亚洲性色| 日本撒尿小便嘘嘘汇集6| 精品人妻熟女av久视频| 国产精品美女特级片免费视频播放器| 99国产精品一区二区蜜桃av| av视频在线观看入口| 欧美zozozo另类| 日本爱情动作片www.在线观看| 综合色丁香网| 观看美女的网站| 国产一区二区三区在线臀色熟女| 综合色av麻豆| 99久久中文字幕三级久久日本| 99久久精品热视频| eeuss影院久久| 九九久久精品国产亚洲av麻豆| 亚洲欧美成人综合另类久久久 | 成人毛片a级毛片在线播放| 亚洲中文字幕日韩| 色综合色国产| 亚洲第一区二区三区不卡| 免费av不卡在线播放| h日本视频在线播放| av福利片在线观看| 三级国产精品欧美在线观看| 国产老妇女一区| 少妇高潮的动态图| 亚洲欧美日韩东京热| 国产白丝娇喘喷水9色精品| 网址你懂的国产日韩在线| ponron亚洲| 欧美日韩在线观看h| 亚洲av男天堂| 日韩欧美三级三区| 色吧在线观看| 亚洲av第一区精品v没综合| 国内精品宾馆在线| 中文字幕免费在线视频6| 免费人成在线观看视频色| 国产精品一二三区在线看| 在线免费十八禁| 亚洲人成网站在线播| 又黄又爽又刺激的免费视频.| 最近的中文字幕免费完整| 国产精品爽爽va在线观看网站| 久久精品人妻少妇| 人人妻人人澡欧美一区二区| 天天躁夜夜躁狠狠久久av| 久久热精品热| av在线观看视频网站免费| 久久人人精品亚洲av| 日韩欧美精品v在线| 村上凉子中文字幕在线| 边亲边吃奶的免费视频| 亚洲精品久久久久久婷婷小说 | 国产精品一区www在线观看| 久久国产乱子免费精品| 精品久久久久久久久亚洲| 91av网一区二区| 久久久成人免费电影| 国产成人精品婷婷| 欧美性猛交黑人性爽| 日韩av在线大香蕉| 麻豆成人午夜福利视频| 在线免费观看不下载黄p国产| 非洲黑人性xxxx精品又粗又长| 国产单亲对白刺激| 校园春色视频在线观看| 97超碰精品成人国产| 12—13女人毛片做爰片一| 一区福利在线观看| 又粗又爽又猛毛片免费看| 中文欧美无线码| 五月伊人婷婷丁香| 国产国拍精品亚洲av在线观看| 欧美一区二区国产精品久久精品| 嫩草影院精品99| 一本久久中文字幕| 国产精品一二三区在线看| 日本在线视频免费播放| 啦啦啦观看免费观看视频高清| 久久鲁丝午夜福利片| 欧美日韩综合久久久久久| 悠悠久久av| 久久国产乱子免费精品| 亚洲国产欧洲综合997久久,| 欧美一区二区国产精品久久精品| 最近视频中文字幕2019在线8| 国产人妻一区二区三区在| 亚洲精品乱码久久久v下载方式| 亚洲不卡免费看| av在线老鸭窝| 国产av麻豆久久久久久久| 日本黄色视频三级网站网址| 久久精品国产亚洲av涩爱 | 亚洲国产精品sss在线观看| 亚洲成人精品中文字幕电影| 村上凉子中文字幕在线| 国产蜜桃级精品一区二区三区| 黑人高潮一二区| 变态另类丝袜制服| 免费大片18禁| 丝袜美腿在线中文| 亚洲精品影视一区二区三区av| 亚洲高清免费不卡视频| 99久久精品国产国产毛片| 国产人妻一区二区三区在| 国产中年淑女户外野战色| 国产精品久久电影中文字幕| 大香蕉久久网| 欧美bdsm另类| 欧美性猛交黑人性爽| 国产黄色小视频在线观看| 九九热线精品视视频播放| 国产精品久久久久久av不卡| 最后的刺客免费高清国语| 免费观看的影片在线观看| 久久国内精品自在自线图片| 老司机影院成人| 最近2019中文字幕mv第一页| 日本黄色片子视频| 久久久a久久爽久久v久久| 欧美潮喷喷水| 日本熟妇午夜| 插逼视频在线观看| 日日啪夜夜撸| 亚洲欧美成人综合另类久久久 | 高清午夜精品一区二区三区 | 乱人视频在线观看| 嫩草影院精品99| 欧美xxxx黑人xx丫x性爽| 成人av在线播放网站| 成年免费大片在线观看| 99热这里只有是精品在线观看| 亚洲一区高清亚洲精品| 中国美白少妇内射xxxbb| 白带黄色成豆腐渣| 成人特级黄色片久久久久久久| 日本黄大片高清| av在线观看视频网站免费| 国产一区二区在线观看日韩| 天堂√8在线中文| 国产黄片视频在线免费观看| 国产精品嫩草影院av在线观看| 啦啦啦啦在线视频资源| 高清毛片免费看| 久久久精品大字幕| kizo精华| 人人妻人人澡人人爽人人夜夜 | 久久精品91蜜桃| 亚洲自拍偷在线| 在线免费观看的www视频| 欧美性感艳星| 日韩高清综合在线| 国产亚洲欧美98| 国产精品麻豆人妻色哟哟久久 | 又粗又硬又长又爽又黄的视频 | 99在线视频只有这里精品首页| 精品一区二区三区视频在线| 国产视频内射| 成人亚洲精品av一区二区| 中文字幕人妻熟人妻熟丝袜美| 亚洲精华国产精华液的使用体验 | 淫秽高清视频在线观看| 国产精品久久久久久av不卡| 少妇熟女欧美另类| 欧美3d第一页| 又黄又爽又刺激的免费视频.| 色5月婷婷丁香| 国产熟女欧美一区二区| 2021天堂中文幕一二区在线观| 草草在线视频免费看| 久久久久久国产a免费观看| 丝袜美腿在线中文| 国产老妇伦熟女老妇高清| 人妻系列 视频| 最近最新中文字幕大全电影3| 国产探花在线观看一区二区| 国产精品一区二区三区四区免费观看| 亚洲一区二区三区色噜噜| 国产三级在线视频| www日本黄色视频网| 精品久久久久久久久av| 精品久久久久久久末码| 麻豆精品久久久久久蜜桃| 黄色欧美视频在线观看| 伦理电影大哥的女人| 日韩欧美 国产精品| 精品国产三级普通话版| 亚洲精品粉嫩美女一区| av卡一久久| 美女高潮的动态| av专区在线播放| 在线观看免费视频日本深夜| 男人舔奶头视频| 亚洲精品色激情综合| 日本一二三区视频观看| 日本黄色片子视频| 久久久久久久亚洲中文字幕| 在线播放无遮挡| 夫妻性生交免费视频一级片| 久久99蜜桃精品久久| 变态另类丝袜制服| 午夜老司机福利剧场| 成年av动漫网址| 欧美+日韩+精品| 日本-黄色视频高清免费观看| 久久精品国产亚洲av香蕉五月| 国产精品女同一区二区软件| 热99re8久久精品国产| 99热这里只有是精品50| 成人高潮视频无遮挡免费网站| av天堂在线播放| 国产一区二区激情短视频| 给我免费播放毛片高清在线观看| 九九爱精品视频在线观看| 成年女人看的毛片在线观看| 午夜福利在线在线| 一级毛片电影观看 | 村上凉子中文字幕在线| 亚洲国产欧洲综合997久久,| 久久国内精品自在自线图片| 高清在线视频一区二区三区 | 麻豆乱淫一区二区| 天堂网av新在线| av.在线天堂| 欧美bdsm另类| 超碰av人人做人人爽久久| 成人性生交大片免费视频hd| 老女人水多毛片| 成人亚洲欧美一区二区av| 日本色播在线视频| av在线天堂中文字幕| 国产美女午夜福利| 国内精品久久久久精免费| 在线观看免费视频日本深夜| 中文欧美无线码| 一级毛片电影观看 | 国产伦精品一区二区三区视频9| 欧美一区二区亚洲| 精品日产1卡2卡| 国产伦一二天堂av在线观看| 国产女主播在线喷水免费视频网站 | 天堂影院成人在线观看| 成人高潮视频无遮挡免费网站| 欧美日本亚洲视频在线播放| 久久久精品94久久精品| 成人av在线播放网站| av专区在线播放| 男女啪啪激烈高潮av片| 床上黄色一级片| 日本欧美国产在线视频| 最近最新中文字幕大全电影3| 国产亚洲精品久久久久久毛片| 高清日韩中文字幕在线| 亚洲va在线va天堂va国产| 欧洲精品卡2卡3卡4卡5卡区| www.av在线官网国产| 自拍偷自拍亚洲精品老妇| av在线天堂中文字幕| 国产精品久久久久久精品电影小说 | 国产成人一区二区在线| 大型黄色视频在线免费观看| 亚洲国产欧洲综合997久久,| 久久久色成人| 日韩视频在线欧美| 不卡一级毛片| 国产蜜桃级精品一区二区三区| а√天堂www在线а√下载| 久久精品国产99精品国产亚洲性色| 内射极品少妇av片p| 国产一区二区在线观看日韩| 欧美激情在线99| 欧美丝袜亚洲另类| 真实男女啪啪啪动态图| 亚洲色图av天堂| 免费观看a级毛片全部| 免费观看人在逋| 亚洲精品456在线播放app| 天天一区二区日本电影三级| 中文字幕av成人在线电影| 综合色av麻豆| 99热6这里只有精品| 久久久欧美国产精品| 日本免费一区二区三区高清不卡| 久久久久久大精品| 国产美女午夜福利| 97超碰精品成人国产| 91午夜精品亚洲一区二区三区| 国产一区二区激情短视频| 乱系列少妇在线播放| 国产激情偷乱视频一区二区| 国产免费一级a男人的天堂| 精品久久久久久久久av| 最近的中文字幕免费完整| 欧美日本视频| 欧美日韩在线观看h| 狠狠狠狠99中文字幕| 女的被弄到高潮叫床怎么办| 婷婷亚洲欧美| 99国产极品粉嫩在线观看| 18禁在线播放成人免费| 校园春色视频在线观看| 国产爱豆传媒在线观看| 97在线视频观看| 亚洲成人久久爱视频| 国产精品电影一区二区三区| 亚洲精品久久久久久婷婷小说 | 老熟妇乱子伦视频在线观看| 国产亚洲精品久久久com| 日本一本二区三区精品| 麻豆久久精品国产亚洲av| 男女边吃奶边做爰视频| 一级黄片播放器| 国产探花极品一区二区| 国产伦精品一区二区三区视频9| 亚洲av免费高清在线观看| 99精品在免费线老司机午夜| 大型黄色视频在线免费观看| 成人漫画全彩无遮挡| 干丝袜人妻中文字幕| 色综合色国产| 免费av毛片视频| 亚洲国产色片| 在线播放无遮挡| 久久精品国产自在天天线| 日韩欧美精品免费久久| 午夜精品一区二区三区免费看| 色哟哟哟哟哟哟| 久久久久久久午夜电影| 成人二区视频| 国产精品1区2区在线观看.| 搡女人真爽免费视频火全软件| 亚洲精品国产av成人精品| 一级毛片aaaaaa免费看小| 亚洲精品乱码久久久久久按摩| 欧美性猛交╳xxx乱大交人| 校园春色视频在线观看| 女同久久另类99精品国产91| 中文精品一卡2卡3卡4更新| 国产视频内射| 婷婷精品国产亚洲av| 亚洲熟妇中文字幕五十中出| 麻豆精品久久久久久蜜桃| 人人妻人人澡人人爽人人夜夜 | 久久久精品94久久精品| 欧美xxxx性猛交bbbb| 亚洲,欧美,日韩| 久久精品国产亚洲av香蕉五月| 精品欧美国产一区二区三| 国产成人一区二区在线| 国产伦精品一区二区三区视频9| 亚洲va在线va天堂va国产| 欧美另类亚洲清纯唯美| 国产av一区在线观看免费| 成人综合一区亚洲| 老熟妇乱子伦视频在线观看| 熟女电影av网| 国产伦一二天堂av在线观看| 黄色配什么色好看| 国产成人a区在线观看| 黄色日韩在线| 亚洲18禁久久av| 久久久久性生活片| 欧美区成人在线视频| or卡值多少钱| 久久精品国产鲁丝片午夜精品| 寂寞人妻少妇视频99o| 成人漫画全彩无遮挡| 亚洲天堂国产精品一区在线| 国产高潮美女av| 色播亚洲综合网| 赤兔流量卡办理| 精华霜和精华液先用哪个| 春色校园在线视频观看| 在线播放无遮挡| 亚洲综合色惰| 青春草国产在线视频 | 日韩欧美 国产精品| 日本免费a在线| 观看免费一级毛片| 国产 一区精品| 国产精华一区二区三区| 日韩欧美在线乱码| 免费电影在线观看免费观看| 99热这里只有精品一区| 国产三级中文精品| 欧美成人一区二区免费高清观看| 免费一级毛片在线播放高清视频| 久久99蜜桃精品久久| 给我免费播放毛片高清在线观看| 久久精品国产亚洲av涩爱 | 99热这里只有精品一区| 日韩av不卡免费在线播放| 一边摸一边抽搐一进一小说| 看黄色毛片网站| 亚洲一级一片aⅴ在线观看| 麻豆av噜噜一区二区三区| 小说图片视频综合网站| 久久久久久大精品| 国产精品麻豆人妻色哟哟久久 | 99热6这里只有精品| 99视频精品全部免费 在线| 岛国在线免费视频观看| 国产伦精品一区二区三区四那| 亚洲美女视频黄频| 久久久久性生活片| 精品熟女少妇av免费看| 最近中文字幕高清免费大全6| 免费人成在线观看视频色| 精品一区二区免费观看| 久久精品国产亚洲网站| 亚洲成人av在线免费| 深爱激情五月婷婷| 一级毛片aaaaaa免费看小| 精品一区二区免费观看| 成人鲁丝片一二三区免费| 12—13女人毛片做爰片一| 99久久无色码亚洲精品果冻| 亚洲欧美成人精品一区二区| 美女国产视频在线观看| 国产精品伦人一区二区| 男女啪啪激烈高潮av片| 免费观看的影片在线观看| 大香蕉久久网| 中国国产av一级| 国产高清三级在线| avwww免费| 国产精品伦人一区二区| 91午夜精品亚洲一区二区三区| 日本一二三区视频观看| 九草在线视频观看| 欧美性猛交黑人性爽| 最近最新中文字幕大全电影3| 黄片wwwwww| 久久99热6这里只有精品| 精品无人区乱码1区二区| 午夜福利在线观看免费完整高清在 | 亚洲精品久久国产高清桃花| 久久精品国产亚洲av涩爱 | 久久久精品大字幕| eeuss影院久久| 啦啦啦啦在线视频资源| 亚洲精品亚洲一区二区| 精品一区二区三区视频在线| 99久久九九国产精品国产免费| 一级毛片久久久久久久久女| a级一级毛片免费在线观看| 黑人高潮一二区| 日韩欧美国产在线观看| 26uuu在线亚洲综合色| 精品无人区乱码1区二区| 国产精品综合久久久久久久免费| 日韩高清综合在线| 成人亚洲欧美一区二区av| 99国产精品一区二区蜜桃av| 国产亚洲精品av在线| 男女边吃奶边做爰视频| 亚洲在线自拍视频| 99久久精品热视频| 别揉我奶头 嗯啊视频| 午夜福利在线在线| 久久久色成人| 永久网站在线| 国产成人影院久久av| 伦理电影大哥的女人| 日本免费a在线| 亚洲欧美成人精品一区二区| 床上黄色一级片| 亚洲欧美日韩高清在线视频| 亚洲av.av天堂| 日本三级黄在线观看| 高清日韩中文字幕在线| 国产精品久久电影中文字幕| 菩萨蛮人人尽说江南好唐韦庄 | 九九热线精品视视频播放| 精品国内亚洲2022精品成人| 国产黄a三级三级三级人| 免费观看精品视频网站| 国产精品人妻久久久影院| 亚洲人成网站高清观看| 丰满的人妻完整版| 国产乱人偷精品视频| 色综合亚洲欧美另类图片| 别揉我奶头 嗯啊视频| 草草在线视频免费看| 国产精品久久电影中文字幕| 午夜a级毛片| 亚洲国产精品久久男人天堂| 在线观看一区二区三区| 亚洲久久久久久中文字幕| 男人舔女人下体高潮全视频| 老司机福利观看| 26uuu在线亚洲综合色| 日本三级黄在线观看| 精品一区二区免费观看| 尤物成人国产欧美一区二区三区| 亚洲美女视频黄频| 亚洲不卡免费看| 菩萨蛮人人尽说江南好唐韦庄 | 国产黄色小视频在线观看| 一个人看视频在线观看www免费| 偷拍熟女少妇极品色| 国产免费男女视频| av视频在线观看入口| 伦理电影大哥的女人| 能在线免费看毛片的网站| h日本视频在线播放| 国产亚洲av嫩草精品影院| av.在线天堂| 99在线视频只有这里精品首页| 99久久久亚洲精品蜜臀av| 51国产日韩欧美| 神马国产精品三级电影在线观看| 免费在线观看成人毛片| 久久人人精品亚洲av| 青春草国产在线视频 | 国产一区二区亚洲精品在线观看| 波多野结衣巨乳人妻|